Molecular Medicine Tri-conference Plenary Session


Plenary Keynote Introductions


MONDAY, FEBRUARY 16


5:00 – 6:00 pm

Plenary Session Introduction:

Robert Penny, M.D., Ph.D., CEO, Paradigm

Integrating the Digital Universe of Data with Consumer-Driven Mobile Apps and Large-Scale Panomics Data to Better Understand, Treat, and Prevent Disease

Eric SchadtEric Schadt, Ph.D., Director of the Icahn Institute for Genomics and Multiscale Biology, Chair of the Department of Genetics and Genomics Sciences; Jean C. and James W. Crystal Professor of Genomics, Icahn School of Medicine at Mount Sinai

The digital universe of data continues to grow at an exponential pace, now comprising more than 1 zettabyte of useable data. Contributing to this big data revolution are panomic technologies, which have made possible the routine sequencing of whole genomes and transcriptomes, and wearable and implantable sensors that make the acquisition of real-time physiologic data across many dimensions a reality in populations of individuals. With extensive molecular, cellular, and physiologic data generated on individuals in a longitudinal fashion, the potential exists to characterize the health of an individual at a far deeper level than has been possible before. Better characterization of an individual’s health will lead to more precise diagnoses, treatments, and preventative strategies for disease at a highly personalized level. Towards this end, we have developed a predictive, multiscale framework that enables us to understand the health of an individual at the molecular, cellular, organ, organism and community scales so that we can better diagnose, treat, and prevent disease.


TUESDAY, FEBRUARY 17


8:00 – 9:00 am

Plenary Session Introduction:

Peter Heseltine, CMO, Singulex, Inc.

Presentation to be Announced

Patrick Soon-ShiongPatrick Soon-Shiong, M.D., Chief Executive Officer, NantHealth

One of the preeminent scientific and medical minds in the world today, Dr. Patrick Soon-Shiong has lent vision, voice, and action to the power of convergence – applying the limitless potential of collaborative science and technology on a personal level – at the speed of thought. A physician, surgeon and scientist, he has pioneered treatments for both diabetes and cancer, published over 100 scientific papers, and holds 50 US patents on groundbreaking advancements across myriad fields.

Dr. Soon-Shiong serves as Chairman of the Chan Soon-Shiong Family Foundation; Chairman and CEO of the Chan Soon-Shiong Institute for Advanced Health (the CSS Institute); the Healthcare Transformation Institute; National LambdaRail; and NantWorks, LLC – a company whose mission is to converge semiconductor technology, supercomputing, advanced networks, and proven innovation to revolutionize how we work, live and play.

Over the course of his celebrated career, Dr. Soon-Shiong has developed and sold two multi-billion dollar pharmaceutical companies. Through the CSS Institute, which assumed responsibility for National LambdaRail in 2011, he is working to create a cutting edge national health information network for the secure sharing of medical information – empowering doctors to treat patients with proven precision at the first point of care.

Among his many positions, Dr. Soon-Shiong is the Executive Director of the UCLA Wireless Health Institute and a board member of the California Telehealth Network. In 2010 the Los Angeles Business Journal recognized him as their Business Person of the Year, and the National Library of Medicine honored him with their Distinguished Medical Science Award.

Dr. Soon-Shiong has garnered vast acclaim as a visionary who has brought forth a fact-based approach to the wonders of science and the wonders of imagination – merging vision with proven application. Harnessing the power of convergence, he has an established record of achievement in bringing together people who are inspired by the impossible and believe progress begins where “possibility” ends.


TUESDAY, FEBRUARY 17


4:10 – 5:00 PM

Join us for this complimentary reception and casually network with other delegates, exhibitors, sponsors, poster presenters, and speakers in an informal, fun setting. Cocktails and light hors d’oeuvres will be served.


WEDNESDAY, FEBRUARY 18


8:00 – 9:45 am

Plenary Session Panel: Emerging Technologies and Industry Perspectives

Panelists:

Bernard Andruss, Ph.D., Vice President, CDx Development and Regulatory Affairs, Asuragen, Inc.

Yuling Luo, Ph.D., CEO and Founder, Advanced Cell Diagnostics

Puneet Sarin, MBA, Vice President & General Manager, Pathology Imaging Business, Leica Biosystems

Lynn Zieske, Ph.D., Principal Scientist, Life Science, Singulex, Inc.

Additional Panelists to be Announced

Sponsored by:

Advanced Cell Diagnostics 

Asuragen 

Biocartis 

Leica Biosystems 

Luminex 

NanoString 

Singulex 

Thomson Reuters 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 

 

2015 MMTC Final Agenda 

Premier Sponsors:

Abbott Molecular 

Elsevier 


Jackson Laboratory - small logo 

Leica Biosystems 
 

 NanoString2   

 

Silicon Biosystems 

 

Singulex 

Thomson Reuters-Large 






Local Partners:

BayBio 


biocube 


Cabs 

City of SSF